Bhattacharya, Amal <br/><br/>
Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD.  [electronic resource] 

 -  International journal of chronic obstructive pulmonary disease  2016 
 - 1469-76 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1178-2005 
<br/><br/><label>Standard No.: </label>10.2147/COPD.S89923  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Adult<br/>Aerosol Propellants--adverse effects<br/>Aged<br/>Albuterol--administration & dosage<br/>Bronchodilator Agents--administration & dosage<br/>Double-Blind Method<br/>Drug Combinations<br/>Equipment Design<br/>Female<br/>Forced Expiratory Volume<br/>Humans<br/>Hydrocarbons, Fluorinated--adverse effects<br/>India<br/>Ipratropium--administration & dosage<br/>Lung--drug effects<br/>Male<br/>Metered Dose Inhalers<br/>Middle Aged<br/>Muscarinic Antagonists--administration & dosage<br/>Pulmonary Disease, Chronic Obstructive--diagnosis<br/>Severity of Illness Index<br/>Therapeutic Equivalency<br/>Time Factors<br/>Treatment Outcome